NEXT GENERATION STROKE TECHNOLOGY

Perfuze is developing innovative medical technology for clot removal in stroke patients

INNOVATION

Scroll to Explore

References

(1) World Stroke Organisation www.world-stroke.org 2020
(2) Mozaffarian et al. Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association. Circulation 2015

ABOUT ISCHEMIC STROKE

RESEARCH

References

(3) Nogueira et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N. Engl. J. Med. 2016
(4) Goyal et al. Endovascular Thrombectomy after Large-Vessel Ischaemic Stroke: A Meta-Analysis of Individual Patient Data from Five Randomised Trials. The Lancet 2016

UNMET CLINICAL NEED

TECHNOLOGY

OUR COMPANY

Perfuze was founded in 2018 by Wayne Allen and Liam Mullins and are located in Galway City in the West of Ireland.

Knowledge